What is NDC 25021-417?

25021-417 is the product NDC for Tirofiban Hydrochloride, Tirofiban hydrochloride 50 ug/mL injection, solution, listed with the FDA by Sagent Pharmaceuticals. It has 1 package NDC, shown above in 10- and 11-digit form.

Sagent Pharmaceuticals, NDC labeler code 25021. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Tirofiban Hydrochloride?

3 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Tirofiban Hydrochloride NDC 25021-417

NDC codes

FDA NDC Directory

Product NDC (as listed)25021-417Labeler and product segments. Claims need a package NDC.

Product NDC at billing width25021-0417Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
25021-417-84	2502104178425021041784	1 BAG in 1 CARTON (25021-417-84) / 250 mL in 1 BAGMarketed from Nov 15, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Tirofiban Hydrochloride
Generic name (nonproprietary): tirofiban hydrochloride
Active ingredients: Tirofiban hydrochloride — 50 ug/mL
Dosage form: Injection, Solution
Route: Intravenous
Labeler: Sagent PharmaceuticalsNDC labeler code 25021
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 206888
Marketing start: Nov 15, 2024
Listing expires: Dec 31, 2026
Other FDA classes: Decreased Platelet Aggregation (Physiologic effect)
Identifiers: Product ID 25021-417_42fc0d8a-6595-491f-aedb-6451129d239dSPL ID 42fc0d8a-6595-491f-aedb-6451129d239dSPL set ID 13ea7fb8-4b01-4286-9464-26c0b624bc3bRxCUI 1737471UNII 6H925F8O5JUPC 0325021417843
Pharmacologic class: Platelet Aggregation Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N425021041784 followed by a unit qualifier and the quantity

Package 25021-0417-84. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 9, 2024.

Indications (excerpt from the label)

Tirofiban hydrochloride injection is indicated to reduce the rate of thrombotic cardiovascular events (combined endpoint of death, myocardial infarction, or refractory ischemia/repeat cardiac procedure) in patients with non-ST elevation acute coronary syndrome (NSTE-ACS). Tirofiban hydrochloride injection is a platelet aggregation inhibitor indicated to reduce the rate of thrombotic cardiovascular events (combined endpoint of death, myocardial infarction, or refractory ischemia/repeat cardiac procedure) in patients with non-ST elevation acute coronary syndrome (NSTE-ACS). ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 25021-417

What is NDC 25021-417?: 25021-417 is the product NDC for Tirofiban Hydrochloride, Tirofiban hydrochloride 50 ug/mL injection, solution, listed with the FDA by Sagent Pharmaceuticals. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Tirofiban Hydrochloride.
What is the active ingredient?: Tirofiban hydrochloride.
Who is the labeler?: Sagent Pharmaceuticals, NDC labeler code 25021. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Tirofiban Hydrochloride?: 3 other product NDCs are listed under this name. See all Tirofiban Hydrochloride NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Tirofiban Hydrochloride NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Tirofiban Hydrochloride	Tirofiban hydrochloride 50 ug/mL	InjectionIntravenous	Nexus Pharmaceuticals LLC	14789-101	14789-0101-01
Tirofiban Hydrochloride	Tirofiban hydrochloride 50 ug/mL	InjectionIntravenous	Nexus Pharmaceuticals LLC	14789-102	14789-0102-0214789-0102-10
Tirofiban hydrochloridetirofiban	Tirofiban hydrochloride 12.5 mg/250mL	Injection, SolutionIntravenous	Gland Pharma Limited	68083-145	68083-0145-01

Other NDCs under ANDA 206888

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 206888
Product	Strength	Form · route	Labeler	Product NDC
Tirofiban hydrochloridetirofiban	Tirofiban hydrochloride 12.5 mg/250mL	Injection, SolutionIntravenous	Gland Pharma Limited	68083-145